Editorial Commentary
Liquid biopsies in renal cell carcinoma with focus on epigenome analysis
Abstract
We read with great interest the recent paper published by Jung et al. in Clinical Chemistry entitled “Cell-free SHOX2 DNA methylation in blood as a molecular staging parameter for risk stratification in renal cell carcinoma patients: a prospective observational cohort study” (1).
